PSMA-PET-Guided Stereotactic Radiotherapy Delays Hormone Therapy for Nearly Three Years in Recurrent Prostate Cancer
A Charité Berlin retrospective study of 60 patients with nodal and bone oligo-recurrent prostate cancer found that early, repeatable PSMA-PET/CT-guided ...

